| Application no. and date | 16706551.5 (espacenet) (Federated) (European Patent Register), 20160209 | | Patent/reg. no. and date | DK/EP 3256109, 20210714 | | Publication date | 20171220 | | Priority no. and date | EP 15154554, 20150210, EP 15188982, 20151008 | | EP pub. no. and date |
EP 3256109 20171220 | | Effective date | | | Applicant/owner | Astex Therapeutics Limited, 436 Cambridge Science Park
Milton Road
Cambridge Cambridgeshire CB4 0QA, GB | | Applicant ref. no. | V2107-054-DK | | Inventor | BROGGINI, Diego Fernando Domenico, c/o Cilag AG
Hochstrasse 201
CH-8200 Schaffhausen, CH | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 31/498 (2006.01) , A61K 47/18 (2017.01) , A61K 9/20 (2006.01) , A61K 9/48 (2006.01) , A61P 35/00 (2006.01) , C07D 403/04 (2006.01) | | Title | FARMACEUTISKE SAMMENSÆTNINGER OMFATTENDE N-(3,5-DIMETHOXYPHENYL)-N'-(1-METHYLETHYL)-N-[3-(1-METHYL-1H-PYRAZOL-4-YL)QUINOXALIN-6-YL]ETHAN-1,2-DIAMIN | | Int. application no. | EP2016052743 | | Int. publication no. | WO2016128411 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
